Distinct evolution of toll-like receptor signaling pathway genes in cetaceans.


Journal

Genes & genomics
ISSN: 2092-9293
Titre abrégé: Genes Genomics
Pays: Korea (South)
ID NLM: 101481027

Informations de publication

Date de publication:
12 2019
Historique:
received: 04 06 2019
accepted: 19 08 2019
pubmed: 20 9 2019
medline: 31 3 2020
entrez: 20 9 2019
Statut: ppublish

Résumé

The relatively rapid spread and diversity of marine pathogens posed an initial and ongoing challenge for cetaceans (whales, dolphins, and porpoises), descendants of terrestrial mammals that transitioned from land to sea approximately 56 million years ago. Toll-like receptors (TLRs) play important roles in regulating immunity against pathogen infections by detecting specific molecular patterns and activating a wide range of downstream signaling pathways. The ever-increasing catalogue of mammalian genomes offers unprecedented opportunities to reveal genetic changes associated with evolutionary and ecological processes. This study aimed to explore the molecular evolution of TLR signaling pathway genes in cetaceans. Genes involved in the TLR signaling pathway were retrieved by BLAST searches using human coding sequences as queries. We tested each gene for positive selection along the cetacean branches using PAML and Hyphy. Physicochemical property changes of amino acids at all positively selected residues were assessed by TreeSAAP and visualized with WebLogo. Bovine and dolphin TLR4 was assessed using human embryonic kidney cell line HEK293, which lacks TLR4 and its co-receptor MD-2. We demonstrate that eight TLR signaling pathway genes are under positive selection in cetaceans. These include key genes in the response to Gram-negative bacteria: TLR4, CD14, and LY96 (MD-2). Moreover, 41 out of 65 positively selected sites were inferred to harbor substitution that dramatically changes the physicochemical properties of amino acids, with most of them situated in or adjacent to functional regions. We also found strong evidence that positive selection occurred in the lineage of the Yangtze finless porpoise, likely reflecting relatively recent adaptions to a freshwater milieu. Species-specific differences in TLR4 response were observed between cetacean and terrestrial species. Cetacean TLR4 was significantly less responsive to lipopolysaccharides from a terrestrial E. coli strain, possibly a reflection of the arms race of host-pathogen co-evolution faced by cetaceans in an aquatic environment. This study provides further impetus for studies on the evolution and function of the cetacean immune system.

Sections du résumé

BACKGROUND
The relatively rapid spread and diversity of marine pathogens posed an initial and ongoing challenge for cetaceans (whales, dolphins, and porpoises), descendants of terrestrial mammals that transitioned from land to sea approximately 56 million years ago. Toll-like receptors (TLRs) play important roles in regulating immunity against pathogen infections by detecting specific molecular patterns and activating a wide range of downstream signaling pathways. The ever-increasing catalogue of mammalian genomes offers unprecedented opportunities to reveal genetic changes associated with evolutionary and ecological processes.
OBJECTIVE
This study aimed to explore the molecular evolution of TLR signaling pathway genes in cetaceans.
METHODS
Genes involved in the TLR signaling pathway were retrieved by BLAST searches using human coding sequences as queries. We tested each gene for positive selection along the cetacean branches using PAML and Hyphy. Physicochemical property changes of amino acids at all positively selected residues were assessed by TreeSAAP and visualized with WebLogo. Bovine and dolphin TLR4 was assessed using human embryonic kidney cell line HEK293, which lacks TLR4 and its co-receptor MD-2.
RESULTS
We demonstrate that eight TLR signaling pathway genes are under positive selection in cetaceans. These include key genes in the response to Gram-negative bacteria: TLR4, CD14, and LY96 (MD-2). Moreover, 41 out of 65 positively selected sites were inferred to harbor substitution that dramatically changes the physicochemical properties of amino acids, with most of them situated in or adjacent to functional regions. We also found strong evidence that positive selection occurred in the lineage of the Yangtze finless porpoise, likely reflecting relatively recent adaptions to a freshwater milieu. Species-specific differences in TLR4 response were observed between cetacean and terrestrial species. Cetacean TLR4 was significantly less responsive to lipopolysaccharides from a terrestrial E. coli strain, possibly a reflection of the arms race of host-pathogen co-evolution faced by cetaceans in an aquatic environment.
CONCLUSION
This study provides further impetus for studies on the evolution and function of the cetacean immune system.

Identifiants

pubmed: 31535317
doi: 10.1007/s13258-019-00861-3
pii: 10.1007/s13258-019-00861-3
doi:

Substances chimiques

Toll-Like Receptors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1417-1430

Références

BMC Evol Biol. 2017 Feb 16;17(1):54
pubmed: 28209121
J Biol Chem. 1995 Sep 8;270(36):21181-7
pubmed: 7545666
J Mol Evol. 2010 Jul;71(1):6-22
pubmed: 20563867
Mol Biol Evol. 2011 May;28(5):1703-15
pubmed: 21239391
Autoimmun Rev. 2016 Jan;15(1):1-8
pubmed: 26299984
Mol Biol Rep. 2012 May;39(5):5669-76
pubmed: 22201021
Mar Drugs. 2014 Apr 30;12(5):2485-514
pubmed: 24796306
J Mol Evol. 2000 Nov;51(5):423-32
pubmed: 11080365
Annu Rev Immunol. 2003;21:335-76
pubmed: 12524386
Nucleic Acids Res. 2017 Jan 4;45(D1):D12-D17
pubmed: 27899561
Nat Rev Genet. 2008 Mar;9(3):165-78
pubmed: 18227810
J Mol Evol. 1998 Apr;46(4):409-18
pubmed: 9541535
Nat Rev Immunol. 2007 May;7(5):353-64
pubmed: 17457343
Mol Biol Evol. 2003 Jan;20(1):18-20
pubmed: 12519901
Vet Immunol Immunopathol. 2007 Jul 15;118(1-2):92-104
pubmed: 17559944
Trends Immunol. 2003 Oct;24(10):528-33
pubmed: 14552836
Vet Immunol Immunopathol. 2010 Feb 15;133(2-4):81-94
pubmed: 19700205
Mar Drugs. 2014 Jul 23;12(7):4260-73
pubmed: 25056632
BMC Evol Biol. 2013 Nov 08;13:245
pubmed: 24209511
Mol Biol Evol. 2007 Aug;24(8):1586-91
pubmed: 17483113
Biochem Biophys Res Commun. 2006 Jun 16;344(4):1200-6
pubmed: 16650380
Mol Biol Evol. 2005 May;22(5):1208-22
pubmed: 15703242
Annu Rev Immunol. 1993;11:191-212
pubmed: 8386518
J Mol Evol. 2007 Aug;65(2):119-23
pubmed: 17762905
Sci Rep. 2016 Mar 02;6:22471
pubmed: 26932528
Nat Rev Immunol. 2015 Jul;15(7):405-14
pubmed: 26027717
Nat Immunol. 2004 Oct;5(10):987-95
pubmed: 15454922
J Mol Evol. 2018 Feb;86(2):138-149
pubmed: 29455279
Nature. 2007 Dec 20;450(7173):1190-4
pubmed: 18097400
Bioinformatics. 2003 Mar 22;19(5):671-2
pubmed: 12651734
J Biol Chem. 2004 Nov 12;279(46):48004-12
pubmed: 15342637
J Exp Med. 1999 Jun 7;189(11):1777-82
pubmed: 10359581
Immunogenetics. 2008 Dec;60(12):727-35
pubmed: 18810425
Nature. 2009 May 14;459(7244):207-12
pubmed: 19444207
J Exp Med. 2007 May 14;204(5):1025-36
pubmed: 17470642
J Biol Chem. 2005 Feb 25;280(8):7010-21
pubmed: 15591054
BMC Genomics. 2008 Feb 01;9:62
pubmed: 18241342
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9577-82
pubmed: 15976025
Nature. 1999 Jun 10;399(6736):541-8
pubmed: 10376593
Mol Biol Evol. 2005 Apr;22(4):1107-18
pubmed: 15689528
J Hered. 2019 May 7;110(3):332-339
pubmed: 30844043
Genome Res. 2004 Jun;14(6):1188-90
pubmed: 15173120
J Interferon Cytokine Res. 1999 Oct;19(10):1069-98
pubmed: 10547147
Mol Biol Evol. 2018 Jun 8;:null
pubmed: 29893911
J Immunol. 2001 Sep 15;167(6):3354-9
pubmed: 11544325
J Wildl Dis. 2012 Jan;48(1):235-7
pubmed: 22247401
Genes (Basel). 2018 Apr 16;9(4):null
pubmed: 29659530
PLoS Genet. 2012;8(7):e1002764
pubmed: 22807683
Mol Biol Evol. 2010 Sep;27(9):2172-86
pubmed: 20410160
BMC Evol Biol. 2016 Feb 09;16:33
pubmed: 26860534
Nat Rev Immunol. 2004 Jul;4(7):499-511
pubmed: 15229469
Nucleic Acids Res. 2015 Jan;43(Database issue):D204-12
pubmed: 25348405
Microbes Infect. 2004 Dec;6(15):1361-7
pubmed: 15596121
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Science. 2003 Mar 28;299(5615):2076-9
pubmed: 12637671
Mol Immunol. 2019 Feb;106:135-142
pubmed: 30597475
Nat Commun. 2018 Apr 10;9(1):1276
pubmed: 29636446
Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7073-8
pubmed: 19359493
Mol Immunol. 2008 Mar;45(5):1298-307
pubmed: 17964652
Mol Immunol. 2010 Feb;47(5):1083-90
pubmed: 20004021
BMC Evol Biol. 2011 Dec 20;11:368
pubmed: 22185391
Bioinformatics. 2005 Mar 1;21(5):676-9
pubmed: 15509596
BMC Evol Biol. 2012 Mar 24;12:39
pubmed: 22443485
Immunogenetics. 2007 Jul;59(7):581-92
pubmed: 17486336
BMC Bioinformatics. 2009 Dec 15;10:421
pubmed: 20003500
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147
PLoS One. 2013 Aug 28;8(8):e72417
pubmed: 24015242
Annu Rev Biochem. 2007;76:141-65
pubmed: 17362201
Mol Biol Evol. 2010 Feb;27(2):221-4
pubmed: 19854763
Mol Phylogenet Evol. 2013 Feb;66(2):479-506
pubmed: 23103570

Auteurs

Ran Tian (R)

Jiangsu Key Laboratory for Biodiversity and Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, Jiangsu, China.
Integrative Biology Laboratory, College of Life Sciences, Nanjing Normal University, Nanjing, Jiangsu, China.

Inge Seim (I)

Integrative Biology Laboratory, College of Life Sciences, Nanjing Normal University, Nanjing, Jiangsu, China.
Comparative and Endocrine Biology Laboratory, Translational Research Institute-Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.

Zepeng Zhang (Z)

Jiangsu Key Laboratory for Biodiversity and Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, Jiangsu, China.

Ying Yang (Y)

Jiangsu Key Laboratory for Biodiversity and Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, Jiangsu, China.

Wenhua Ren (W)

Jiangsu Key Laboratory for Biodiversity and Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, Jiangsu, China.

Shixia Xu (S)

Jiangsu Key Laboratory for Biodiversity and Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, Jiangsu, China. xushixia78@163.com.

Guang Yang (G)

Jiangsu Key Laboratory for Biodiversity and Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, Jiangsu, China. gyang@njnu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH